China Struggles to Expand Commercial Insurance Coverage for Innovative Drugs, Report Says

Despite efforts to ease pressure on state-run healthcare, commercial insurers covered just 7.8% of the country’s innovative drug and device market last year, as pricing, data and access barriers continue to constrain growth

Raccontata dacaixinglobal.com